INDICATIONS AND USAGE Etoposide capsules are indicated in the management of the following neoplasms: Small Cell Lung Cancer Etoposide capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
mylan pharmaceuticals inc.
ETOPOSIDE capsules, USP are available containing 50 mg of
ETOPOSIDE, USP. The 50 mg capsule is an opaque dark pink, soft gelatin capsule printed with E50 in black ink. They are available as follows: NDC 0378-3266-94 20 capsules - Unit Dose capsules are to be stored under refrigeration, between 2Â° to 8Â°C (36Â° to 46Â°F). Protect from freezing. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site